Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference (Form 8-K)

Sotera Health to Showcase Continued Revenue

Growth and Strategic Value Creation at

44th Annual J.P. Morgan Healthcare Conference

CLEVELAND, OH, January 12, 2026 - Sotera Health Company ("Sotera Health" or the "Company") (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, is presenting today at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health's business.

"Sotera Health continued its solid growth trajectory in 2025, with revenue expected to surpass $1.16 billion, an increase of at least 5.5% year over year, or 5.0% on a constant-currency basis," said Chairman and Chief Executive Officer Michael B. Petras, Jr. "This marks over two decades of year-over-year revenue growth, reflecting the durability of our business model, the strength and consistency of our financial profile, and our continued commitment to serve our customers with excellence. We look forward to sharing our full-year results and 2026 outlook on February 24, 2026."

A live webcast of the presentation, along with accompanying materials, will be available on the Investor Relations section of the Company's website at Presentation & Events | Sotera Health. A replay will be available within 48 hours following the presentation and will remain archived on the Company's website.